Literature DB >> 15077905

Somatostatin receptors and regulation of cell proliferation.

C Bousquet1, J Guillermet, F Vernejoul, H Lahlou, L Buscail, C Susini.   

Abstract

Somatostatin is an inhibitory neuropeptide, which acts on various targets throughout the body to regulate a variety of physiological functions including inhibition of endocrine and exocrine secretions, modulation of neurotransmission, motor and cognitive functions, inhibition of intestinal motility, absorption of nutrients and ions, vascular contractility and inhibition of normal and tumour cell proliferation. It exerts its effects through interaction with five somatostatin receptors (sst1-sst5), which belong to the family of G-protein-coupled receptors with seven transmembrane spanning domains and are variably expressed in a variety of tumours such as gastroenteropancreatic tumours, pituitary tumours, and carcinoid tumours. This review covers the present knowledge regarding the molecular mechanisms involved in somatostatin antineoplastic activity. Evidence that sst2 receptor acts as a tumour suppressor is also discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15077905     DOI: 10.1016/j.dld.2003.11.007

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  10 in total

1.  Somatostatin receptor subtypes in hormone-refractory (castration-resistant) prostatic carcinoma.

Authors:  Roberta Mazzucchelli; Doriana Morichetti; Marina Scarpelli; Aldo V Bono; Antonio Lopez-Beltran; Liang Cheng; Ziya Kirkali; Rodolfo Montironi
Journal:  Asian J Androl       Date:  2010-12-13       Impact factor: 3.285

2.  Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway.

Authors:  Corinne Bousquet; Julie Guillermet-Guibert; Nathalie Saint-Laurent; Elodie Archer-Lahlou; Frédéric Lopez; Marjorie Fanjul; Audrey Ferrand; Daniel Fourmy; Carole Pichereaux; Bernard Monsarrat; Lucien Pradayrol; Jean-Pierre Estève; Christiane Susini
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

Review 3.  Somatostatin analogs for gastric carcinoids: For many, but not all.

Authors:  Sara Massironi; Alessandra Zilli; Dario Conte
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

4.  Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer.

Authors:  Roberta Mazzucchelli; Doriana Morichetti; Alfredo Santinelli; Marina Scarpelli; Aldo V Bono; Antonio Lopez-Beltran; Liang Cheng; Rodolfo Montironi
Journal:  Cell Oncol (Dordr)       Date:  2011-04-30       Impact factor: 6.730

5.  Somatostatin inhibits cell migration and reduces cell counts of human keratinocytes and delays epidermal wound healing in an ex vivo wound model.

Authors:  Matthias Vockel; Simone Pollok; Ute Breitenbach; Ina Ridderbusch; Hans-Jürgen Kreienkamp; Johanna M Brandner
Journal:  PLoS One       Date:  2011-05-11       Impact factor: 3.240

Review 6.  Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: a message not well taken.

Authors:  Dimitrios N Samonakis; George Notas; Nikolaos Christodoulakis; Elias A Kouroumalis
Journal:  Dig Dis Sci       Date:  2008-02-14       Impact factor: 3.199

7.  Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer.

Authors:  Hanane Laklai; Séverine Laval; Laurent Dumartin; Philippe Rochaix; Martin Hagedorn; Andreas Bikfalvi; Sophie Le Guellec; Marie-Bernadette Delisle; Andrew V Schally; Christiane Susini; Stéphane Pyronnet; Corinne Bousquet
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-01       Impact factor: 11.205

8.  Promoter hypermethylation-related reduced somatostatin production promotes uncontrolled cell proliferation in colorectal cancer.

Authors:  Katalin Leiszter; Ferenc Sipos; Orsolya Galamb; Tibor Krenács; Gábor Veres; Barna Wichmann; István Fűri; Alexandra Kalmár; Árpád V Patai; Kinga Tóth; Gábor Valcz; Zsolt Tulassay; Béla Molnár
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

Review 9.  Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways.

Authors:  Mehtap Cakir; Dorota Dworakowska; Ashley Grossman
Journal:  J Cell Mol Med       Date:  2010-11       Impact factor: 5.310

Review 10.  Antitumoral and Anti-inflammatory Roles of Somatostatin and Its Analogs in Hepatocellular Carcinoma.

Authors:  Argyrios Periferakis; Georgios Tsigas; Aristodemos-Theodoros Periferakis; Ioana Anca Badarau; Andreea-Elena Scheau; Mircea Tampa; Simona Roxana Georgescu; Andreea Cristiana Didilescu; Cristian Scheau; Constantin Caruntu
Journal:  Anal Cell Pathol (Amst)       Date:  2021-11-27       Impact factor: 2.916

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.